Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Upstream stimulatory factor 2 (USF2) is a ubiquitously expressed basic helix-loop-helix leucine zipper transcription factor that modulates gene expression by binding conserved E-box motifs in DNA. USF2 participates in the regulation of diverse biological processes including cell proliferation, differentiation, metabolism, stress response, immune function, and tissue-specific gene regulation. Dysregulation of USF2 contributes to enhanced proliferation and immortality in cancer cells, influences steroid biosynthesis in endocrine tissues, and is linked to pathological states such as fibrosis, hepatocellular carcinoma, and endometriosis. USF2 interacts with other transcription factors (notably USF1) and responds to both environmental and cellular cues, positioning it as a pivotal node in transcriptional control, but it is not established as a direct therapeutic target or receptor[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Upstream stimulatory factor 2 (USF2).